Anterix (ATEX) EBIT (2013 - 2025)

Anterix has reported EBIT for 13 years, with the latest figure at -$9.1 million in Q4 2025.

• For the quarter ending Q4 2025, EBIT fell 228.85% year-over-year to -$9.1 million; the trailing twelve-month figure through Dec 2025 stood at $83.5 million (up 364.04% YoY), and the FY2025 full-year result was -$11.7 million, down 15.73% from the prior year.
• EBIT for Q4 2025 stood at -$9.1 million, down from $60.7 million in the prior quarter.
• The five-year high for EBIT was $60.7 million in Q3 2025, with the low at -$15.0 million in Q2 2024.
• Historically, EBIT has averaged -$613150.0 across 5 years, with a median of -$8.7 million in 2022.
• The largest YoY upside for EBIT was 625.7% in 2024 against a maximum downside of 681.23% in 2024.
• Anterix's EBIT stood at -$12.4 million in 2021, then surged by 32.09% to -$8.4 million in 2022, then jumped by 111.53% to $969000.0 in 2023, then surged by 625.7% to $7.0 million in 2024, then sank by 228.85% to -$9.1 million in 2025.
• The last three EBIT figures came in at -$9.1 million (Q4 2025), $60.7 million (Q3 2025), and $22.5 million (Q2 2025), per Business Quant data.